throbber
Antigens and Enzymes Made Insoluble by Entrapping
`Them into Lattices of Synthetic Polymers
`Biologically active, insoluble products have been prepared from
`Abstract.
`soluble antigens or enzymes by entrapping them into the lattice of an insoluble,
`highly cross-linked synthetic polymer as it forms. Antigens, made insoluble,
`removed quantitatively certain or all antibiotics from complex mixtures. Seven
`enzymes so treated are described.
`Soluble
`previously
`antigens
`have
`been rendered insoluble either by cou-
`pling the proteins with diazotized cel-
`(1 )
`lulose derivatives
`or by linking
`them to the acid chloride of a carboxyl-
`ated
`(2).
`Also,
`resin
`ion-exchange
`insoluble forms of amylase, pepsin, car-
`boxypeptidase, and ribonuclease have
`been obtained by coupling with diazo-
`tized polyaminostyrene (3), and insol-
`uble
`was obtained
`by
`ribonuclease
`absorption on a Dowex-50 cation-
`exchange resin
`(4). Tryspin (5) and
`papain (6) were transformed into in-
`soluble derivatives by the introduction
`of polytyrosyl peptide side chains. This
`reaction is not applicable without con-
`siderable modifications to other proteins,
`or protein mixtures. Insoluble proteins
`obtained by coupling with diazotized
`polymers or by attachment to ion-ex-
`partial
`change resins
`suffered
`either
`denaturation during these reactions or
`exhibited partial reversibility of the ab-
`sorption, under certain conditions (5).
`We have obtained biologically active,
`insoluble forms of antigens, enzymes,
`material
`macromolecular
`and
`other
`(for example, amylopectin), by me-
`chanically entrapping the soluble ma-
`cromolecular product into the lattice
`of a highly cross-linked synthetic poly-
`mer by polymerizing certain synthetic
`monomers in aqueous solution in the
`presence of the biologically active ma-
`cromolecular substance to be embedded.
`which
`polyacrylamide,
`Cross-linked
`in an aqueous medium
`polymerizes
`and which has been used as a support-
`ing medium for zone electrophoresis
`(7), is eminently suited for this pur-
`pose. We have used two methods for
`rendering proteins or other macromo-
`lecular biologically active material in-
`soluble, depending on the purpose for
`which the resulting products are to be
`used. For rendering proteins or other
`antigens insoluble (procedure I) 50 mg
`of antigen are added to 200 mg of
`acrylamide, 120 mg of N,N' methylene-
`bisacrylamide, 5.6 mg of tetramethyl-
`ethylenediamine, 0.5 mg of Al NH4-
`(SO4)2' 12 H20, and 1 ml of (1M) tris
`1 ml
`buffer, pH 8.6, all diluted to
`
`Downloaded from
`
`http://science.sciencemag.org/
`
`
`
`on March 28, 2018
`
`with water. At the last, 2.5 mg of
`potassium persulfate
`are added. For
`rendering enzymes insoluble (procedure
`II), 2 mg of the enzyme are added to
`a mixture similar to the one described
`for procedure I except that the acryl-
`amide is omitted and the amount of
`the potassium persulfate added is 5 mg.
`In both procedures, the mixture is
`kept for 1 hour at 35°C without agita-
`tion after the polymerization catalyst
`(potassium persulfate) has been added.
`The insoluble synthetic polymer thus
`formed is dispersed mechanically, cen-
`trifuged for 30 minutes in a Sorvall
`centrifuge, model RC-2, rotor SS-34,
`at 17,000 rev/min (34,000g), and is
`washed by mixing it with 20 ml water
`and subsequent centrifugation. A total
`of three washings for procedure I and
`16 washings for procedure II are neces-
`sary.
`
`Table 1. Activity of crystalline enzyme (9)
`entrapped in the synthetic polymer prepara-
`tion and the residual activity remaining in
`solution after the removal of the synthetic
`is
`the
`polymer.
`The "entrapped"
`activity
`percentage of total amount of enzyme pres-
`ent during the polymerization reaction. The
`is measured by first in-
`"residual"
`activity
`cubating the substrate at 250 to 350 C with
`insoluble enzyme for periods ranging from 25
`to 180 minutes, cooling the mixture to 0°C,
`and removing the insoluble enzyme by cen-
`trifugation and subsequent filtration, and in-
`cubating the remaining solution at 250
`to
`350C for 18 to 22 hours. Residual enzyme
`activity
`activity
`expressed
`is
`in
`percent
`per unit of time before centrifugation.
`Activity
`Residual in
`supernatant
`solution
`(%)
`4-5.5 t
`Trypsin *
`0.65
`0.77
`a-Chymotrypsin *
`4.5
`Papain *
`0.57
`3.4-6 t
`ca-Amylase t §
`0.7
`1.9
`3-Amylase
`0.3
`6.55

`0.89
`4.6
`Ribonuclease 1
`0.52
`4.2
`Aldolase * *
`digestion method
`casein
`* Determined by the
`t Two separate experiments.
`t From
`(10).
`§ Determined by the reducto-
`hog pancreas.
`metric method with dinitrosalicylic acid reagent
`II From sweet potatoes.
`I From beef
`(11).
`pancreas; activity determined by the spectrophoto-
`** From rabbit mus-
`metric method (12, 13).
`cle; activity determined by the method of Taylor
`et al. (14).
`
`Entrapped
`(%)
`
`Enzyme
`
`SCIENCE, VOL. 142
`
`awaits definitive biochemical and bio-
`logical studies.
`The control diet at Darrah Springs,
`diet
`8, contained 19 percent cotton-
`In contrast, diet 9 (liver
`seed meal.
`and cottonseed meal)
`contained 37
`percent cottonseed meal when calcu-
`lated on a dry-weight basis. Yet at the
`end of 10 months, 40 out of 50 trout
`in the group fed on diet 8 had gross
`hepatomas, but neither gross nor mi-
`croscopic tumors were found in the 50
`trout sampled from the group fed on
`At the end of 23 months,
`diet
`9.
`among 65 fish fed on diet 9 only 3
`These ob-
`gross tumors were found.
`servations suggest that liver markedly
`the hepatoma-inducing effect
`inhibits
`of the cottonseed meal, but does not
`completely suppress it. Nakahara et al.
`(10) have demonstrated the inhibitive
`effect of a diet containing liver on
`hepatoma induction by butter yellow
`(dimethyl-amino-azobenzene)
`rats,
`in
`and a similar effect may be operating
`in this instance.
`The results obtained with diets 2 and
`4 obscure the significance of the four
`microscopic tumors found in diet
`6.
`With the omission of wheat middlings
`in diet 4, the incidence of hepatomas
`was no lower than in the control group;
`with diet 2, no hepatomas were found,
`although the diet included 25 percent
`wheat middlings.
`For these reasons,
`we believe that this component played
`no significant role in the outbreak of
`hepatomas in California during 1960,
`when the incidence of tumors in very
`young fish was extremely high (11).
`HAROLD WOLF
`California Department of Fish
`and Game, Sacramento
`
`E. W. JACKSON
`California Department of Public
`Health, Berkeley
`
`References and Notes
`1. A. Haddow and J. Blake, J. Pathol. Bacteriol.
`36, 41 (1933).
`2. G. Cudkowicz and C. Scolari, Tutmori 41, 524
`(1935).
`3. R. F. Nigrelli, Trans. Amer. Fisheries Soc.
`83, 262 (1954).
`4. J. H. Wales, personal communication (1960).
`5. J. Ellis, personal communication (1960).
`6. R. R. Rucker, W. T. Yasutake, H. Wolf,
`Progressiv,e Fish Culturist 23 (1961).
`7. E. M. Wood and C. P. Larson, Arch. Pathol.
`71, 471 (1961).
`8. W. C. Hueper and W. W. Payne, J. Natl.
`Cancer Inst. 27, 1123 (1961).
`9. "Summary of Trout Hepatoma Survey," U.S.
`Fish and Wildlife Service, Bureau of Sport
`Fish and Wildlife, Sept. (1960).
`10. W. Nakahara, K. Mon, T. Fujiwara, Gann
`33, 406 (1939).
`11. This investigation was supported in part by
`Public Health Service grant No. C-5924 from
`the National Cancer Institute.
`14 August 1963
`
`678
`
`Reactive Surfaces Ltd. LLP Ex. 1019 - Page 1
`
`

`

`I
`
`Downloaded from
`
`http://science.sciencemag.org/
`
`
`
`on March 28, 2018
`
`A
`B
`C
`Fig. 1. Antigen-antibody interactions by the agar plate diffusion technique of Ouchter-
`lony. All center wells (in A, B, and C) contain rabbit antiserum specific for whole
`human serum and for crystalline bovine serum albumin. Center well in A, antiserum
`treated with insoluble human serum protein (prepared from pooled whole human
`serum). Center well in B, antiserum untreated (control). Center well in C, antiserum
`treated with insoluble bovine albumin (prepared from crystallized bovine serum albu-
`min). The outside wells have the same arrangement in A, B, and C, that is, upper and
`lower left, bovine serum albumin (157 ug per ml); upper right: whole human serum
`(1:128 dilution); lower right, mixture of whole human serum (1:128) with bovine
`albumin (157 pg per ml).
`
`(see Table 1). After centrifugation and
`filtration, more than 99 percent of the
`enzyme activity had been removed from
`the mixture in all cases (residual ac-
`tivity was less than one percent of the
`activity before centrifugation).
`The
`rendered
`enzymes
`insoluble
`maintained their activity when stored
`to 4°C. A ribonuclease prepara-
`at O0
`tion, for instance, exhibited 90 percent
`of the original activity after one month.
`There was no indication that the en-
`properties
`zymatic
`of
`the
`insoluble
`products were in any way different from
`those of the corresponding soluble ma-
`terials and, in particular, the pH opti-
`ma of activity were unchanged. In the
`tests made, contact with the substrate
`did not release even traces of any of
`the entrapped enzymes.
`Freshly prepared
`insoluble papain
`was active in the absence of added
`sulfhydryl agents or of cyanide, and
`was not activated by any of these mate-
`rials;
`this
`is comparable to the pa-
`pain derivative described by Cebra et
`al. (6). Our insoluble papain prepara-
`tion completely lost its enzyme activity
`when stored for 3 days at 00 to 4°C
`(air was not excluded); however, it
`could be reactivated by cysteine.
`Biological activity of antigens or en-
`zymes requires contact with antibodies
`or substrates,
`respectively, but most
`antibodies,
`and many enzyme sub-
`strates, are macromolecular substances
`and hence are unable to penetrate into
`the particles of the cross-linked poly-
`the same reason that
`mer for
`the
`trapped antigens or enzymes cannot
`get out. It appears likely therefore that,
`
`while the entrapped antigen or enzyme
`may be located both inside and near
`the surface of the insoluble particles,
`only the latter portion exhibits biologi-
`cal activity. Actually, considerably more
`than 2 to 6 percent of the original en-
`zyme (or antigen) may be entrapped
`(Table 1) but may not exhibit biologi-
`activity
`cal
`for
`of
`steric
`reasons
`hindrance (8).
`
`PETER BERNFELD
`J. WAN
`
`Bio-Research Institute,
`Cambridge, Massachusetts
`
`References and Notes
`1. D. H. Campbell, E. Luescher, L. S. Lerman,
`Proc. Natl. Acad. Sci. U.S. 37, 575 (1951).
`2. H. C. Isliker, Ann. N.Y. Acad. Sci. 57, 225
`(1953).
`3. N. Grubhofer and L. Schleith, Naturwissen-
`schaften 40, 508 (1953).
`4. L. B. Barnett and H. B. Bull, Blochim. Bio-
`phys. Acta 36, 244 (1959).
`5. A. Bar-Eli and E. Katchalski, Nature 188,
`856 (1960).
`6. J.
`Cebra, D. Givol, H. I.
`J.
`Silman,
`E.
`Katchalski, J. Biol. Chem. 236, 1720 (1961).
`7. S. Raymond and L. Weintraub, Science 130,
`711 (1959).
`8. Supported in part by grant CA-03852 from the
`National Institutes of Health, by grant P-249
`from the American Cancer Society, and by
`a grant from the National Science Founda-
`tion.
`9. Aldolase was purchased from Mann Research
`Laboratories;
`all
`other enzymes were pur-
`chased from Worthington Biochemical Corp.
`Insoluble hyaluronidase from a bovine testes
`preparation, with 300 USP units per milli-
`gram, has also been obtained.
`10. M. Kunitz, J. Gen. Physiol. 30, 291 (1947).
`11. G. Noelting and P.
`Bernfeld, Helv. Chim.
`Acta 31, 286 (1948); P. Bernfeld, in Methods
`in Enzymology, S. P. Colowick and N. 0.
`Kaplan, Eds. (Academic Press, New York,
`1955), vol. 1, p. 149.
`12. M. Kunitz, J. Biol. Chem. 164, 563 (1946).
`13. C. B. Anfinsen, R. R. Redfield. W. L. Choate,
`J. Page, W. R. Carroll, ibid. 207, 201 (1954).
`14. J. F. Taylor, A. A. Green, G. T. Cori, ibid.
`173, 591 (1948).
`9 September 1963
`
`679
`
`The first procedure (I) yields a gel-
`like, insoluble synthetic polymer which
`can be easily and completely removed
`from the suspension by centrifugation;
`particular mechanical
`because of its
`properties, this material is not suitable,
`however, for accurately measuring out
`or pipetting samples of its suspension.
`The second procedure (II) results in a
`flocculent product which lends itself
`well to quantitative measurement, but
`separation of the solid from the liquid
`phase is more difficult.
`To use insoluble antigens for the
`absorption of antibodies, the solid ma-
`terial obtained after the last washing
`(procedure I) is mixed with 1 ml of
`an antiserum (for example, rabbit anti-
`serum against whole human serum),
`and the suspension is kept under con-
`stant agitation (by means of a Boerner
`for 2 hours at
`oscillating platform)
`room temperature. The insoluble anti-
`gen is then removed by centrifugation
`at 34,000g, and the protein concentra-
`tion of the remaining solution is ad-
`justed to that of the antiserum before
`treatment by lyophilizing and dissolving
`the residue in water.
`The photographs of the antibody-
`antigen reactions in Fig. I show that
`antibodies against a mixture of a large
`number of antigens (whole human se-
`rum) can be quantitatively removed by
`this method (Fig 1A, upper and lower
`right), while the antibody against an
`additional antigen, which was absent
`from the mixture of insoluble antigens
`used (bovine serum albumin), is totally
`unaffected (Fig. 1A, upper and lower
`Inversely, a single
`left, lower right).
`antibody can be selectively removed
`from a complex mixture of antibodies
`(against whole human serum and bo-
`vine serum albumin) when its pure
`antigen (crystalline bovine serum al-
`bumin) is available (Fig. 1C).
`insoluble
`with
`For reactions
`en-
`zymes, a portion of the suspension of
`insoluble enzyme (procedure
`is
`II)
`mixed with the appropriate substrate
`and buffer solutions, and the mixture
`is incubated under continuous agitation
`by means of a Boerner oscillating plat-
`form. The enzyme reaction is arrested
`by centrifugation of the mixture at
`34,000g and subsequent filtration of the
`supernatant solution through a What-
`man No. 1 filter.
`Between 2 and 6 percent of the en-
`zyme activity, present during the poly-
`merization reaction, appeared in the
`exhaustively washed synthetic polymer
`8 NOVEMBER 1963
`
`Reactive Surfaces Ltd. LLP Ex. 1019 - Page 2
`
`

`

`Downloaded from
`
`http://science.sciencemag.org/
`
`
`
`on March 28, 2018
`
`Antigens and Enzymes Made Insoluble by Entrapping Them into Lattices of Synthetic
`Polymers
`Peter Bernfeld and J. Wan
`
`142
`Science 
` (3593), 678-679.
`DOI: 10.1126/science.142.3593.678
`
`ARTICLE TOOLS
`
`http://science.sciencemag.org/content/142/3593/678
`
`REFERENCES
`
`This article cites 13 articles, 7 of which you can access for free
`http://science.sciencemag.org/content/142/3593/678#BIBL
`
`PERMISSIONS
`
`http://www.sciencemag.org/help/reprints-and-permissions
`
`Use of this article is subject to the
`
`Terms of Service
`
`Science
`(print ISSN 0036-8075; online ISSN 1095-9203) is published by the American Association for the
`Advancement of Science, 1200 New York Avenue NW, Washington, DC 20005. 2017 © The Authors, some rights
`reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S.
`
` is a registered trademark of AAAS.Science
`Government Works. The title
`
`Reactive Surfaces Ltd. LLP Ex. 1019 - Page 3
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket